483 results on '"Lindner, Lars H."'
Search Results
2. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma
3. Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience
4. The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials
5. Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline “Adult Soft Tissue Sarcomas”
6. A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers
7. Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or Excipients
8. Diagnostic accuracy of biopsy after neoadjuvant treatment for well-differentiated and dedifferentiated retroperitoneal liposarcoma
9. Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group
10. Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial
11. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
12. Systemische Therapie von Osteosarkomen: Wege aus der prognostischen Stagnation?
13. Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model
14. Retroperitoneale Weichgewebssarkome: Stellenwert der Radiotherapie
15. Unplanned Resections of Soft Tissue Sarcomas—Necessity of Re-Resection?
16. Regional hyperthermia for soft tissue sarcoma – a survey on current practice, controversies and consensus among 12 European centers
17. Treatment of metastatic alveolar soft part sarcoma with axitinib and pembrolizumab in an 80-year-old patient with a history of autoimmune disorders
18. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study
19. Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study
20. Studien zu Weichteilsarkomen und Knochentumoren in Deutschland
21. Neues zu Weichteilsarkomen
22. The AYA gap for rhabdomyosarcoma
23. Neues zu Weichteilsarkomen.
24. Cannabis in der Onkologie – viel Rauch um nichts?
25. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma
26. Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
27. Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
28. Supplementary Table S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
29. Data from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
30. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
31. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial
32. 18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor
33. Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review
34. External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis
35. TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)
36. KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
37. Supplementary Video 2 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
38. Data from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
39. Supplementary Video 1 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
40. Supplementary Materials and Methods from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
41. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors
42. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors
43. Systemische Therapie von Osteosarkomen
44. Retroperitoneale Weichgewebssarkome: Stellenwert der Radiotherapie
45. Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.
46. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
47. Cannabis in der Onkologie – viel Rauch um nichts?
48. Hyperthermie
49. Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial
50. Nanomedicine-based strategies for treatment of atherosclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.